Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Jul-Aug;52(4):472-9, 1-9.
doi: 10.1331/JAPhA.2012.10194.

Pharmacy staff characteristics associated with support for pharmacy-based HIV testing

Silvia Amesty  1 , Shannon Blaney, Natalie D Crawford, Alexis V Rivera, Crystal Fuller
Affiliations
Randomized Controlled Trial

Pharmacy staff characteristics associated with support for pharmacy-based HIV testing

Silvia Amesty et al. J Am Pharm Assoc (2003). 2012 Jul-Aug.

Abstract

Objectives: To determine support of in-pharmacy human immunodeficiency virus (HIV) testing among pharmacy staff and the individual-level characteristics associated with in-pharmacy HIV testing support.

Design: Descriptive, nonexperimental, cross-sectional study.

Setting: New York City (NYC) from January 2008 to March 2009.

Participants: 480 pharmacy staff, including pharmacists, owners/managers, and technicians/clerks.

Intervention: 131 pharmacies registered in the Expanded Syringe Access Program (ESAP) completed a survey.

Main outcome measure: Support of in-pharmacy HIV testing.

Results: Support of in-pharmacy HIV testing is high among pharmacy staff (79.4%). Pharmacy staff who supported in-pharmacy vaccinations were significantly more likely to support in-pharmacy HIV testing. Pharmacy staff who thought that selling syringes to injection drug users (IDUs) caused the community to be littered with dirty syringes were significantly less likely to support in-pharmacy HIV testing.

Conclusion: Support for in-pharmacy HIV testing was high among our sample of ESAP pharmacy staff actively involved in nonprescription syringe sales. These findings suggest that active ESAP pharmacy staff may be amenable to providing HIV counseling and testing to IDUs and warrants further investigation.

PubMed Disclaimer

Conflict of interest statement

We disclose that there are no potential conflicts of interest or financial interests.

References

    1. The New York Academy of Medicine. New York State Expanded Syringe Access Demonstration Program Evaluation. Evaluation Report to the Governor and the New York State Legislatures. 2003
    1. Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Journal of the American Pharmaceutical Association. 2002;42(Suppl 2):S77–S82. - PubMed
    1. Deren S, Fuller CM, Pouget ER, Blaney S, Tortu S, Kang S, McMahon JM, Andia JF, Jarlais DC, Johnson B, Rosenblum A, Vlahov D. Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. The International Journal of Drug Policy. 14(2003):373–379.
    1. Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Int J Drug Policy. 2007 Oct;18(5):417–425. - PubMed
    1. Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S, Muzaffar R, Andreasen A, Hawkes S. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic. Sex Transm Infect. 2009 Apr;85(Suppl 2):ii17–ii22. - PubMed

Publication types